Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression
Withdrawn
University of Alabama at Birmingham
N/A
2010-04-01
This study is dedicated to achieving a better understanding of how the brain processes
information. Specifically, the investigators are studying cognitive function, thought
process, and impulsivity in people with and without suicidal thoughts. You are being asked to
participate in a research study to learn how the use of a medication, risperidone, improves
your symptoms of depression. Specifically the investigators are studying the effectiveness of
reducing the thought of suicide and other symptoms of severe depression. Risperidone is
approved by FDA for the treatment of schizophrenia and bipolar mania, and clinical practice
suggests that it might benefit patients with major depressive disorder. During clinical
trials with 2607 patients, risperidone was proved to be safe. This is a pilot study to test a
new indication of risperidone for treatment of severe depression. The study medication will
be given in addition to usual psychiatric care.
This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and
risperidone (Risperdal®) can help patients with first-episode schizophrenia.
This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and
risperidone (Risperdal®) can help patients with first-episode schizophrenia.
This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and
risperidone (Risperdal®) can help patients with first-episode schizophrenia.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.